Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability

genesis ◽  
2010 ◽  
pp. NA-NA ◽  
Author(s):  
Hiroshi Kiyonari ◽  
Mari Kaneko ◽  
Shin-ichi Abe ◽  
Shinichi Aizawa
Stem Cells ◽  
2008 ◽  
Vol 26 (6) ◽  
pp. 1436-1443 ◽  
Author(s):  
Kristi A. Hohenstein ◽  
April D. Pyle ◽  
Jing Yi Chern ◽  
Leslie F. Lock ◽  
Peter J. Donovan

2016 ◽  
Vol 44 (16) ◽  
pp. 7997-8010 ◽  
Author(s):  
Brian R. Shy ◽  
Matthew S. MacDougall ◽  
Ryan Clarke ◽  
Bradley J. Merrill

2020 ◽  
Author(s):  
Eishi Aizawa ◽  
Charles-Etienne Dumeau ◽  
Remo Freimann ◽  
Giulio Di Minin ◽  
Anton Wutz

AbstractIn mammals, the fusion of two gametes, an oocyte and a spermatozoon, during fertilization forms a totipotent zygote. There has been no reported case of natural parthenogenesis, in which embryos develop from unfertilized oocytes. The genome and epigenetic information of haploid gametes are crucial for the proper development of embryos. Haploid embryonic stem cells (haESCs) are unique stem cells established from uniparental blastocysts and possess only one set of chromosomes. Previous studies have shown that sperm or oocyte genome can be replaced by haESCs with or without manipulation of genomic imprinting for generation of mice. Recently, these remarkable semi-cloning methods have been applied for screening of key factors of mouse embryonic development. While haESCs have been applied as substitute of gametic genome, the fundamental mechanism how haESCs contribute to the genome of totipotent embryos is unclear. Here, we show the generation of fertile semi-cloned mice by injection of parthenogenetic haESCs (phaESCs) into oocytes after deletions of two differentially methylated regions (DMRs), the IG-DMR and H19-DMR. For characterizing the genome of semi-cloned embryos further we establish ESC lines from semi-cloned blastocysts. We report that polyploid karyotypes are observed frequently in semi-cloned ESCs (scESCs). Our results confirm that mitotically arrested phaESCs provide high efficiency for semi-cloning when the IG-DMR and H19-DMR are deleted. In addition, we highlight the occurrence of polyploidy that needs to be considered for further improvement for development of semi-cloned embryos derived by haESC injection.


2001 ◽  
Vol 13 (8) ◽  
pp. 523 ◽  
Author(s):  
Alan O. Trounson

Human embryonic stem cells lines can be derived from human blastocysts at high efficiency (>50%) by immunosurgical isolation of the inner cell mass and culture on embryonic fibroblast cell lines. These cells will spontaneously differentiate into all the primary embryonic lineages in vitro and in vivo, but they are unable to form an integrated embryo or body plan by themselves or when combined with trophectoderm cells. They may be directed into a number of specific cell types and this enrichment process requires specific growth factors, cell-surface molecules, matrix molecules and secreted products of other cell types. Embryonic stem (ES) cells are immortal and represent a major potential for cell therapies for regenerative medicine. Their use in transplantation may depend on the formation of a large bank of suitable human leucocyte antigen (HLA) types or the genetic erasure of their HLA expression. Successful transplantation may also require induction of tolerance in recipients and ongoing immune suppression. Although it is possible to customize ES cells by therapeutic cloning or cytoplasmic transfer, it would appear unlikely that these strategies will be used extensively for producing ES cells compatible for transplantation. Embryonic stem cell research may deliver a new pathway for regenerative medicine.


2009 ◽  
Vol 7 (1) ◽  
pp. 53-55 ◽  
Author(s):  
Matthias Stadtfeld ◽  
Nimet Maherali ◽  
Marti Borkent ◽  
Konrad Hochedlinger

Sign in / Sign up

Export Citation Format

Share Document